[Paper Review] Role of Antibodies: A Novel Paradigm in Mathematical Modeling for Cancer Treatment

Shiferaw Feyissa, Sandip Banerjee|arXiv (Cornell University)|Jun 25, 2010

Mathematical Biology Tumor Growth16 references3 citations

TL;DR

This paper proposes a novel mathematical model of cancer-immune interaction that explicitly incorporates the direct cytotoxic role of antibodies, as supported by clinical evidence. Using bifurcation analysis and numerical simulations, it demonstrates that monoclonal antibody therapy can drive the system toward a cancer-free equilibrium by altering key parameters, offering a quantitative framework for optimizing antibody-based treatments.

ABSTRACT

A mathematical model for the quantitative analysis of cancer immune interaction, considering the role of antibodies has been proposed in this paper. The model is based on the clinical evidence, which states that antibodies can directly kill cancerous cells [1]. The existence of transcritical and saddle-node bifurcation, which has been proved using Sotomayor theorem, provides strong biological implications. Through numerical simulations, it has been illustrated that under certain therapy (like monoclonal antibody therapy), which is capable of altering the parameters of the system, cancer-free state can be obtained.

Motivation & Objective

• To develop a mathematical model that quantitatively captures the role of antibodies in directly killing cancer cells, based on clinical evidence.
• To analyze the dynamical behavior of the cancer-immune interaction system using bifurcation theory.
• To investigate whether monoclonal antibody therapy can shift the system dynamics toward a cancer-free equilibrium.
• To provide a theoretical basis for optimizing antibody-based cancer treatments through parameter manipulation.

Proposed method

• The model is formulated as a system of ordinary differential equations representing interactions between cancer cells, immune cells, and antibodies.
• The role of antibodies is modeled as a direct cytotoxic effect on cancer cells, consistent with clinical observations.
• Sotomayor's theorem is applied to analytically prove the existence of transcritical and saddle-node bifurcations in the system.
• Numerical simulations are used to explore the system’s behavior under varying therapy-induced parameter changes.
• Parameter space is manipulated to simulate monoclonal antibody therapy and assess its impact on system stability.

Experimental results

Research questions

• RQ1 Can a mathematical model that includes direct antibody-mediated killing of cancer cells reproduce clinically observed dynamics?
• RQ2 What types of bifurcations emerge in the cancer-immune-antibody system, and what do they imply biologically?
• RQ3 Under what conditions can monoclonal antibody therapy drive the system to a stable cancer-free equilibrium?
• RQ4 How do changes in therapy parameters influence the stability and long-term behavior of the system?

Key findings

• The model exhibits transcritical and saddle-node bifurcations, indicating critical transitions in system behavior that align with biological thresholds.
• The existence of these bifurcations suggests that small changes in therapy parameters can lead to qualitative shifts in disease outcome.
• Numerical simulations confirm that monoclonal antibody therapy can stabilize the system in a cancer-free equilibrium.
• The system's transition to a cancer-free state is contingent on the effective modulation of key parameters by therapeutic intervention.